Dental Pulp Stem Cell Secretome Shows Promise for Stroke Recovery in Mice

When a stroke strikes, the damage does not end when blood flow returns. In the hours and days that follow reperfusion, a cascade of oxidative stress, runaway inflammation, and neuronal death can quietly erode the brain’s remaining capacity for repair, leaving many survivors with lasting impairments in movement, memory, and cognition. Current clinical interventions, from clot-busting drugs to mechanical thrombectomy, are remarkably effective at restoring perfusion, but they offer only partial protection against this delayed wave of secondary injury. A new study from South Korea now suggests that an unexpected biological resource, the proteins and vesicles secreted by stem cells harvested from human dental pulp, may help the injured brain fight back.

The research, led by Professor Won-Jae Kim of the Stem Cell Secretome Research Center in the Department of Oral Physiology at Chonnam National University School of Dentistry, investigated whether the secretome of human dental pulp stem cells, or hDPSCs, could improve functional recovery after ischemic stroke. The work, published online on July 23, 2026, in the journal Advanced Science, combined proteomic profiling, cell-based assays, and a photothrombotic mouse model of ischemic stroke to map both the molecular contents of the secretome and its downstream effects on the injured brain. The central idea is elegant in its simplicity: rather than transplanting living stem cells, clinicians could one day deliver the cocktail of bioactive molecules those cells naturally release.

That distinction matters more than it might first appear. Cell transplantation therapies have long been haunted by practical obstacles, including poor survival of grafted cells, immune rejection, and the theoretical risk of tumorigenesis. Secretome-based approaches sidestep these problems entirely, because the therapeutic agents are cell-free. As Professor Kim explained, utilizing the bioactive factors secreted by stem cells rather than the cells themselves overcomes the classic hurdles of cell transplantation. His team wanted to determine whether the hDPSC secretome could serve as a safe, supportive treatment to mitigate secondary brain injury, modulate neuroinflammation, and accelerate neural repair after a stroke.

To understand what makes the dental pulp secretome special, the researchers first catalogued its contents. Proteomic analysis identified 299 proteins uniquely present in the hDPSC secretome, and their functions clustered around themes that read like a wish list for neuroprotection: extracellular vesicles, immunomodulation, neuroprotection, angiogenesis, apoptosis regulation, and resistance to oxidative stress. Several proteins stood out for their roles in antioxidant defense, including SOD2, GSR, and GSTP1, which are tied directly to the brain’s antioxidant network. Others, notably GRN, CSF1, and LRP1, emerged as key regulators of microglial phenotype, positioning the secretome to influence the brain’s resident immune cells at a critical moment.

In laboratory dishes, those molecular assets translated into measurable protection. When microglial cells, the brain’s primary immune sentinels, were treated with the hDPSC secretome, their viability improved, oxidative stress declined, and mitochondrial function was restored. The treatment reinstated expression of Mfn2, a protein essential for mitochondrial fusion, and SOD1, a key antioxidant enzyme, while reducing levels of HIF-1α, a transcription factor associated with hypoxic stress. Just as importantly, the secretome suppressed microglial migration and inflammation, nudging these cells away from the pro-inflammatory M1 phenotype and toward the pro-healing, repair-associated M2 state. In the aftermath of a stroke, that shift in microglial polarity can mean the difference between a brain that continues to destroy its own tissue and one that begins to rebuild.

The animal experiments brought these cellular effects into a living, injured brain. Using a photothrombotic model of ischemic stroke, in which a targeted clot-like lesion is induced in a defined cortical region, the researchers administered the hDPSC secretome and tracked both structural and molecular outcomes. Treated mice showed significantly reduced infarct volume and markedly less neuronal apoptosis in both the cortex and the hippocampus, two regions central to motor and cognitive function. At the molecular level, the secretome activated the Nrf2/HO-1 pathway, a master regulator of cellular antioxidant responses, while suppressing TLR4, the NOX1–NOX4 NADPH oxidase system, and NF-κB signaling, three interconnected drivers of oxidative damage and inflammation.

The regenerative effects extended well beyond damage control. In the treated animals, the secretome promoted the proliferation of neural stem cells and their differentiation into new neurons, hinting at genuine neurogenesis in the injured brain. It also restored vascular density, a process consistent with angiogenesis and vascular remodeling that can improve blood supply to recovering tissue. Perhaps most strikingly, the treatment helped rebuild synaptic architecture: levels of synaptophysin and PSD95, two cornerstone proteins of functional synapses, were upregulated in the treated brains, suggesting that the secretome was not merely preserving surviving neurons but actively supporting the reconnection of neural circuits.

Those structural and molecular changes were mirrored in behavior. Stroke-injured mice that received the secretome showed dramatic improvements in physical balance, motor coordination, and sensory-motor responses compared with untreated animals. The cognitive benefits were equally broad. Across Barnes maze, cross-maze, and fear-conditioning paradigms, treated mice demonstrated significant improvements in spatial learning, working memory, and associative memory. The treatment even reduced post-stroke anxiety-like behaviors, a common and often overlooked consequence of stroke that can profoundly affect quality of life. Taken together, the behavioral data indicate that the secretome’s effects penetrate multiple functional domains rather than narrowly rescuing a single task.

The broader implications reach past stroke. Because the secretome targets fundamental mechanisms shared by many neurological conditions, including oxidative stress, mitochondrial dysfunction, and maladaptive inflammation, the same platform could eventually be applied to other devastating brain disorders. Professor Kim noted that over the next decade, secretome-based therapies could transform stroke care by limiting brain damage and actively repairing neural networks, and that because the approach targets fundamental mechanisms like inflammation and cellular stress, it could eventually be extended to disorders such as Alzheimer’s and Parkinson’s disease. That vision depends on a critical next step: standardizing the active therapeutic components of the hDPSC secretome so that treatments become safer, more reliable, and widely accessible, rather than varying from batch to batch.

For now, the findings remain anchored in cell culture and mouse models, and the path from a photothrombotic lesion in a laboratory animal to a therapy for human stroke survivors will require careful dose optimization, delivery studies, and clinical trials. Yet the study offers a compelling proof of concept that the bioactive cargo of dental pulp stem cells, tissue that is routinely discarded after tooth extractions, can reprogram redox and inflammatory signaling in the injured brain and translate that molecular rescue into restored movement, learning, and memory. If subsequent work confirms and standardizes these effects, the humble tooth could become an unlikely source of one of neurology’s most versatile regenerative medicines, offering stroke survivors not just survival, but recovery.

Subject of Research: Therapeutic potential of human dental pulp stem cell secretome for functional recovery after ischemic stroke

Article Title: Chonnam National University study explores therapeutic potential of human dental pulp stem cell secretome in post-stroke functional recovery

Article References: Chonnam National University study explores therapeutic potential of human dental pulp stem cell secretome in post-stroke functional recovery. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: ischemic stroke, dental pulp stem cells, secretome, neuroinflammation, oxidative stress, neurogenesis, microglia, Nrf2 pathway, neuroprotection, angiogenesis, synaptic recovery, cell-free therapy